PLP2 Expression as a Prognostic and Therapeutic Indicator in High-Risk Multiple Myeloma

Figure 2

PLP2 was linked to myeloma progression. (a–d) β2-MG, LDH, bone marrow infiltration, and ISS stages were expressed the highest in the high PLP2 expression subgroup, while the lowest in the low PLP2 expression subgroup (). (e–g) β2-MG and CRP were expressed the highest in the PLP2^high subgroup, while ALB was expressed the lowest in the PLP2^high subgroup (, ).

(a)

(b)

(c)

(d)

(e)

(f)

(g)